Aurobindo Pharma Limited (AUROPHARMA) - Total Assets

Latest as of March 2026: Rs585.02 Billion INR ≈ $6.33 Billion USD

Based on the latest financial reports, Aurobindo Pharma Limited (AUROPHARMA) holds total assets worth Rs585.02 Billion INR (≈ $6.33 Billion USD) as of March 2026. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.

Aurobindo Pharma Limited - Total Assets Trend (2004–2026)

This chart illustrates how Aurobindo Pharma Limited's total assets have evolved over time, based on quarterly financial data. Also see market value of Aurobindo Pharma Limited for the company's overall valuation and market capitalisation.

Aurobindo Pharma Limited - Asset Composition Analysis

Current Asset Composition (March 2026)

Aurobindo Pharma Limited's total assets of Rs585.02 Billion consist of 55.9% current assets and 44.1% non-current assets. Review total liabilities of Aurobindo Pharma Limited to assess the company's total debt and financial obligations.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs0.00	16.9%
Accounts Receivable	Rs71.12 Billion	12.2%
Inventory	Rs120.53 Billion	20.6%
Property, Plant & Equipment	Rs0.00	0.0%
Intangible Assets	Rs44.81 Billion	7.7%
Goodwill	Rs8.00 Billion	1.4%

Asset Composition Trend (2004–2026)

This chart illustrates how Aurobindo Pharma Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. See AUROPHARMA live share price for real-time trading data and today's change.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Aurobindo Pharma Limited's current assets represent 55.9% of total assets in 2026, an increase from 51.4% in 2004.
Cash Position: Cash and equivalents constituted 16.9% of total assets in 2026, up from 3.3% in 2004.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 8.0% of total assets, an increase from 1.0% in 2004.
Asset Diversification: The largest asset category is inventory at 20.6% of total assets.

Aurobindo Pharma Limited Competitors by Total Assets

Key competitors of Aurobindo Pharma Limited based on total assets are shown below.

Company	Country	Total Assets
Beijing Tongrentang Co Ltd SHG:600085	China	CN¥29.95 Billion
Hubei Jumpcan Pharmaceutical Co Ltd SHG:600566	China	CN¥17.01 Billion
Shijiazhuang Yiling Pharmaceutical Co Ltd SHE:002603	China	CN¥13.98 Billion
Shenzhen Kangtai Biological Products Co Ltd SHE:300601	China	CN¥13.93 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
Sun Pharma Advanced Research Company Limited NSE:SPARC	India	Rs3.22 Billion
ChengDa Pharmaceuticals Co. Ltd. SHE:301201	China	CN¥2.35 Billion

Aurobindo Pharma Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	1.81	1.85	1.86
Quick Ratio	1.15	1.13	1.01
Cash Ratio	0.00	0.56	0.00
Working Capital	Rs146.70 Billion	Rs124.80 Billion	Rs91.58 Billion

Aurobindo Pharma Limited - Advanced Valuation Insights

This section examines the relationship between Aurobindo Pharma Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.50
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	17.5%
Total Assets	Rs585.02 Billion
Market Capitalization	$10.65 Billion USD

Valuation Analysis

Below Book Valuation: The market values Aurobindo Pharma Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Aurobindo Pharma Limited's assets grew by 17.5% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Aurobindo Pharma Limited (2004–2026)

The table below shows the annual total assets of Aurobindo Pharma Limited from 2004 to 2026.

Year	Total Assets	Change
2026-03-31	Rs585.02 Billion ≈ $6.33 Billion	+17.51%
2025-03-31	Rs497.85 Billion ≈ $5.38 Billion	+10.46%
2024-03-31	Rs450.72 Billion ≈ $4.87 Billion	+12.99%
2023-03-31	Rs398.90 Billion ≈ $4.31 Billion	+17.59%
2022-03-31	Rs339.22 Billion ≈ $3.67 Billion	+0.20%
2021-03-31	Rs338.54 Billion ≈ $3.66 Billion	+17.03%
2020-03-31	Rs289.28 Billion ≈ $3.13 Billion	+9.35%
2019-03-31	Rs264.54 Billion ≈ $2.86 Billion	+25.37%
2018-03-31	Rs211.01 Billion ≈ $2.28 Billion	+29.86%
2017-03-31	Rs162.49 Billion ≈ $1.76 Billion	+2.07%
2016-03-31	Rs159.20 Billion ≈ $1.72 Billion	+23.27%
2015-03-31	Rs129.14 Billion ≈ $1.40 Billion	+36.09%
2014-03-31	Rs94.90 Billion ≈ $1.03 Billion	+30.39%
2013-03-31	Rs72.78 Billion ≈ $787.07 Million	+16.68%
2012-03-31	Rs62.38 Billion ≈ $674.58 Million	+6.22%
2011-03-31	Rs58.72 Billion ≈ $635.06 Million	+22.56%
2010-03-31	Rs47.91 Billion ≈ $518.16 Million	+13.36%
2009-03-31	Rs42.26 Billion ≈ $457.08 Million	+16.29%
2008-03-31	Rs36.34 Billion ≈ $393.06 Million	+3.65%
2007-03-31	Rs35.06 Billion ≈ $379.21 Million	+30.38%
2006-03-31	Rs26.89 Billion ≈ $290.85 Million	+26.28%
2005-03-31	Rs21.30 Billion ≈ $230.33 Million	+14.14%
2004-03-31	Rs18.66 Billion ≈ $201.79 Million	--

About Aurobindo Pharma Limited

NSE:AUROPHARMA India Drug Manufacturers - Specialty & Generic

Market Cap

$10.65 Billion

Rs985.05 Billion INR

Market Cap Rank

#2129 Global

#88 in India

Share Price

Rs1712.00

Change (1 day)

-0.23%

52-Week Range

Rs1070.80 - Rs1734.00

All Time High

Rs1734.00